The Pros and Cons of Targeting Protein Kinase c (PKC) in the Management of Cancer Patients

Publisher: Bentham Science Publishers

E-ISSN: 1873-4316|12|11|1961-1973

ISSN: 1389-2010

Source: Current Pharmaceutical Biotechnology, Vol.12, Iss.11, 2011-11, pp. : 1961-1973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract